Dr. Martin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 NE Neff Rd
Bend, OR 97701Phone+1 541-706-5800Fax+1 541-706-6341
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2002 - 2005
Spokane Teaching Health CenterResidency, Internal Medicine, 1999 - 2002
University of Washington School of MedicineClass of 1999
Certifications & Licensure
OR State Medical License 2005 - 2025
MN State Medical License 2002 - 2006
WA State Medical License 2001 - 2003
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- 1 citationsSouthwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma.Christopher D Lao, James Moon, Vincent T Ma, John P Fruehauf, Lawrence E Flaherty
Cancer. 2025-01-01 - 45 citationsSerum-free light chain—a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemiaWilliam P. Martin, Roshini S. Abraham, Tait D. Shanafelt, Raynell J. Clark, Nancy D. Bone
Translational Research. 2007-04-01 - 196 citationsBleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's LymphomaWilliam G. Martin, Kay M. Ristow, Thomas M. Habermann, Joseph P. Colgan, Thomas E. Witzig
Journal of Clinical Oncology. 2005-10-20
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
